Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Vincenzo Minotti"'
Autor:
Sara Baglivo, Fortunato Bianconi, Giulio Metro, Alessio Gili, Francesca Romana Tofanetti, Guido Bellezza, Biagio Ricciuti, Martina Mandarano, Valeria Teti, Annamaria Siggillino, Maria Sole Reda, Rita Chiari, Lorenza Pistola, Angelo Sidoni, Vincenzo Minotti, Fausto Roila, Vienna Ludovini
Publikováno v:
Genes, Vol 12, Iss 7, p 992 (2021)
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, their clinical benefit is limited to a minority of patients. To unravel immune-related factors that are predictive of sensitivity or resistance to immunoth
Externí odkaz:
https://doaj.org/article/9616edf7ce244c6bae96a87a6b11bd3e
Autor:
Giulio Metro, Sara Baglivo, Guido Bellezza, Martina Mandarano, Alessio Gili, Giovanni Marchetti, Marco Toraldo, Carmen Molica, Maria Sole Reda, Francesca Romana Tofanetti, Annamaria Siggillino, Enrico Prosperi, Antonella Giglietti, Bruna Di Girolamo, Miriam Garaffa, Francesca Marasciulo, Vincenzo Minotti, Marco Gunnellini, Annalisa Guida, Monica Sassi, Angelo Sidoni, Fausto Roila, Vienna Ludovini
Publikováno v:
Genes, Vol 12, Iss 5, p 679 (2021)
Besides platinum-based chemotherapy, no established treatment option exists for advanced non-small-cell lung cancer (NSCLC) patients with EGFR exon 20 (Ex20ins) insertion mutations. We sought to determine the clinical outcome of patients with this EG
Externí odkaz:
https://doaj.org/article/70b79d0f7ed14f21accc9fc53fac23d1
Autor:
Vienna Ludovini, Fortunato Bianconi, Annamaria Siggillino, Jacopo Vannucci, Sara Baglivo, Valeria Berti, Francesca Romana Tofanetti, Maria Sole Reda, Guido Bellezza, Martina Mandarano, Maria Laura Belladonna, Giulio Metro, Rita Chiari, Angelo Sidoni, Francesco Puma, Vincenzo Minotti, Fausto Roila
Publikováno v:
Genes, Vol 12, Iss 2, p 273 (2021)
Programmed death ligand 1 (PD-L1) expression is a predictive biomarker of the success of PD-1/PD-L1 inhibitor therapy for patients with advanced non-small cell lung cancer (NSCLC) but its role as a prognostic marker for early-stage resectable NSCLC r
Externí odkaz:
https://doaj.org/article/aaf6da29727a4ccda922f5fb887eb0ae
Autor:
Annamaria Siggillino, Paola Ulivi, Luigi Pasini, Maria Sole Reda, Elisa Chiadini, Francesca Romana Tofanetti, Sara Baglivo, Giulio Metro, Lucio Crinó, Angelo Delmonte, Vincenzo Minotti, Fausto Roila, Vienna Ludovini
Publikováno v:
Diagnostics, Vol 10, Iss 12, p 1062 (2020)
Analysis of circulating cell-free tumor DNA (cftDNA) has emerged as a specific and sensitive blood-based approach to detect epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients. Still, there is some debate
Externí odkaz:
https://doaj.org/article/fd3f3ec7ec2447269d94d487d5b4507b
Autor:
Sara Baglivo, Martina Mandarano, Guido Bellezza, Vincenzo Minotti, Angelo Bonaiti, Matthias J. Fischer, Ilaria Birocchi, Fausto Roila, Niccolò Metelli, Vienna Ludovini, Giulio Metro
Publikováno v:
Oncology and Therapy. 10:291-300
Treatment with immune checkpoint inhibitors (ICIs) that target the programmed cell death 1/programmed cell death ligand-1 (PD-1/PD-L1) axis is usually ineffective in patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small cel
Autor:
M. Reni, E. Giommoni, F. Bergamo, M. Milella, L. Cavanna, M.C. Di Marco, M. Spada, S. Cordio, G. Aprile, G.G. Cardellino, E. Maiello, I. Bernardini, M. Ghidini, S. Bozzarelli, M. Macchini, G. Orsi, I. De Simone, Er. Rulli, L. Porcu, V. Torri, C. Pinto, Michele Reni, Marina Macchini, Giulia Orsi, Umberto Peretti, Mariamaddalena Valente, Elisa Giommoni, Lorenzo Antonuzzo, Francesco Di Costanzo, Francesca Bergamo, Vittorina Zagonel, Sara Lonardi, Federica Buggin, Michele Milella, Silvia Palmerio, Luigi Cavanna, Camilla Di Nunzio, Maria Cristina Di Marco, Elisa Grassi, Massimiliano Spada, Marco Messina, Stefano Cordio, Francesco Avola, Giuseppe Aprile, Salvatore Pagano, Francesca Simionato, Giovanni Gerardo Cardellino, Federica Majer, Evaristo Maiello, Tiziana Pia Latiano, Cinzia Chiarazzo, Fabrizio Artioli, Giorgia Razzini, Antonella Pasqualini, Michele Ghidini, Elisa Binda, Silvia Lazzarelli, Silvia Bozzarelli, Simona Sala, Gabriele Luppi, Elisa Pettorelli, Andrea Spallanzani, Giovanni Vicario, Flavia Salmaso, Marco Basso, Nicola Silvestris, Sabina Del Curatolo, Fable Zustovich, Francesca Bongiovanni, Ciro Longobardi, Ilenia Sandi, Caterina Fontanella, Silvia Montelatici, Monica Giordano, Giovanna Luchena, Micol Gilardoni, Emiliano Tamburini, Britt Rudnas, Barbara Venturini, Barbara Merelli, Giorgia Negrini, Elio Maria Vici, Alessandra Marabese, Cristina Garetto, Paola Curcio, Saverio Cinieri, Margherita Cinefra, Pasqualinda Ferrara, Maurizio Cantore, Patrizia Morselli, Guglielmo Fumi, Agnese Isidori, Giovanni Ciccarese, Giovanni Luca Paolo Frassineti, Flavia Pagan, Vanja Vaccaro, Chiara Spoto, Marianna Ferrara, Carlo Garufi, Marta Caporale, Enrico Vasile, Francesca Salani, Elisa Barone, Rossana Berardi, Azzurra Onofri, Zelmira Ballatore, Alessandra Lucarelli, Alessandra Barucca, Amedeo Pancotti, Teresa Scipioni, Katia Bencardino, Giovanna Marrapese, Laura Idotta, Fausto Petrelli, Veronica Lonati, Anna Ceribelli, Angelo Giuli, Cristina Zannori, Maria Bassanelli, Andrea Mambrini, Laura Ginocchi, Massimo Orlandi, Luigi Celio, Monica Niger, Lavinia Biamonte, Stefano Tamberi, Alessandra Piancastelli, Giorgio Papiani, Irene Valli, Paolo Allione, Maria Giovanna Boe, Mario Scartozzi, Eleonora Lai, Annagrazia Pireddu, Pina Ziranu, Laura Demurtas, Marco Puzzoni, Stefano Mariani, Andrea Pretta, Nicole Liscia, Clementina Savastano, Valentina Malaspina, Giuseppe Tonini, Teresa Grassani, Barbara Barco, Tagliaferri Pierosandro, Domenico Ciliberto, Antonella Ierardi, Natale Daniele Calandruccio, Vincenzo Minotti, Roberta Matocci, Valter Torri, Luca Porcu, Erica Rulli, Irene De Simone, Luciano Carlucci, Eliana Rulli, Davide Poli, Paola Tonto, Francesca Scellato, Carmine Pinto
Background: Information about the adherence to scientific societies guidelines in the ‘real-world’ therapeutic management of oncological patients are lacking. This multicenter, prospective survey was aimed to improve the knowledge relative to 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f827f8705c922ff764aa383826811530
https://hdl.handle.net/11585/919206
https://hdl.handle.net/11585/919206
Autor:
Giulio Metro, Angelo Bonaiti, Ilaria Birocchi, Francesca Marasciulo, Martina Ubaldi, Niccolò Metelli, Vincenzo Minotti, Alfredo Addeo
Publikováno v:
J Thorac Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7937bcfcb5d78cf09a8ac5eca82cdfc6
https://europepmc.org/articles/PMC9096286/
https://europepmc.org/articles/PMC9096286/
Autor:
Fausto Roila, Fortunato Bianconi, Lorenza Pistola, Francesca Romana Tofanetti, Vincenzo Minotti, Martina Mandarano, Alessio Gili, Annamaria Siggillino, Biagio Ricciuti, Vienna Ludovini, Guido Bellezza, Angelo Sidoni, Giulio Metro, Valeria Teti, Sara Baglivo, Maria Sole Reda, Rita Chiari
Publikováno v:
Genes
Genes, Vol 12, Iss 992, p 992 (2021)
Volume 12
Issue 7
Genes, Vol 12, Iss 992, p 992 (2021)
Volume 12
Issue 7
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, their clinical benefit is limited to a minority of patients. To unravel immune-related factors that are predictive of sensitivity or resistance to immunoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79cfc058c98e749406bef4d49451038
http://hdl.handle.net/11391/1502382
http://hdl.handle.net/11391/1502382
Autor:
Fausto Roila, Annamaria Siggillino, Angelo Delmonte, Paola Ulivi, Sara Baglivo, Vienna Ludovini, Vincenzo Minotti, Giulio Metro, Francesca Romana Tofanetti, Elisa Chiadini, Lucio Crinò, Luigi Pasini, Maria Sole Reda
Publikováno v:
Diagnostics
Volume 10
Issue 12
Diagnostics, Vol 10, Iss 1062, p 1062 (2020)
Volume 10
Issue 12
Diagnostics, Vol 10, Iss 1062, p 1062 (2020)
Analysis of circulating cell-free tumor DNA (cftDNA) has emerged as a specific and sensitive blood-based approach to detect epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients. Still, there is some debate
Autor:
Daniela Colabrese, Daniela Zicari, Marta Brambilla, Vincenzo Minotti, Giulia Costanza Leonardi, Biagio Ricciuti, Alessandro D'arpino, Rita Chiari, Elisa Minenza, Giulio Metro, Marco Tazza, Sara Baglivo, Irene Soli
Publikováno v:
Expert Opinion on Drug Safety. 16:101-109
Immune checkpoint blockaders (ICBs) act by unbalancing the immune system, thus favoring the development of an immune-mediated antitumor effect. ICBs targeting the programmed cell death receptor-1 (PD-1) have recently been investigated in a number of